Stevens First Principles Investment Advisors’s Pfizer PFE Stock Holding History

Stevens First Principles Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$1.51M	Buy	36,781 +117	+0.3%	+$4.65K	0.88%	34
2019 Q1	$1.48M	Buy	36,664 +1,006	+3%	+$40.3K	0.88%	33
2018 Q4	$1.48M	Buy	35,658 +833	+2%	+$34.6K	1%	34
2018 Q3	$1.46M	Buy	34,825 +363	+1%	+$14K	0.84%	35
2018 Q2	$1.19M	Buy	34,462 +1,489	+5%	+$50.9K	0.71%	38
2018 Q1	$1.11M	Buy	32,973 +52	+0.2%	+$1.79K	0.68%	38
2017 Q4	$1.13M	Buy	32,921 +2,151	+7%	+$73.3K	0.61%	43
2017 Q3	$1.04M	Sell	30,770 -211	-0.7%	-$6.78K	0.57%	43
2017 Q2	$987K	Buy	30,981 +853	+3%	+$26.9K	0.58%	45
2017 Q1	$978K	Buy	30,128 +1,286	+4%	+$40.5K	0.62%	42
2016 Q4	$889K	Buy	28,842 +3,674	+15%	+$112K	0.62%	41
2016 Q3	$809K	Buy	25,168 +3,267	+15%	+$109K	0.58%	44
2016 Q2	$732K	Buy	21,901 +2,551	+13%	+$81.4K	0.55%	44
2016 Q1	$544K	Sell	19,350 -2,663	-12%	-$76.1K	0.44%	44
2015 Q4	$674K	Hold	22,013	–	–	0.57%	40
2015 Q3	$656K	Hold	22,013	–	–	0.52%	46
2015 Q2	$700K	Sell	22,013 -7,546	-26%	-$246K	0.45%	58
2015 Q1	$976K	Hold	29,559	–	–	0.63%	44
2014 Q4	$874K	Sell	29,559 -1,745	-6%	-$50K	0.58%	50
2014 Q3	$878K	Sell	31,304 -495	-2%	-$13.9K	0.49%	58
2014 Q2	$895K	Hold	31,799	–	–	0.49%	58
2014 Q1	$969K	Buy	31,799 +184	+0.6%	+$5.49K	0.63%	53
2013 Q4	$919K	Sell	31,615 -42	-0.1%	-$1.22K	0.54%	56
2013 Q3	$863K	Hold	31,657	–	–	0.51%	58
2013 Q2	$841K	Buy	+31,657	New	+$875K	0.59%	52

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stevens First Principles Investment Advisors's PFE Position: Q2 2019 in Review

Stevens First Principles Investment Advisors increased its Pfizer (PFE) stake by 0.32% in Q2 2019, buying an estimated $4.65K and bringing the position to 36,781 shares worth $1.51M. The position accounts for 0.88% of the portfolio, ranked #34.

Stevens First Principles Investment Advisors first reported a position in PFE in Q2 2013 and has held it in 25 quarters since. 2,378 funds tracked by Wall St. Rank hold PFE as of Q2 2019.

Stevens First Principles Investment Advisors held 36,781 shares of Pfizer worth $1.51M as of Q2 2019.
Stevens First Principles Investment Advisors bought 117 Pfizer shares in Q2 2019, an estimated $4.65K.
Pfizer made up 0.88% of Stevens First Principles Investment Advisors's portfolio in Q2 2019, its #34 holding.
Stevens First Principles Investment Advisors first reported a position in Pfizer in Q2 2013 and has held it in 25 quarters since.
2,378 funds tracked by Wall St. Rank held Pfizer as of Q2 2019.

Based on Stevens First Principles Investment Advisors's 13F filing for Q2 2019, filed 22 Jul 2019.